Latest media releases


UBS Global Life Sciences Conference opens in New York

New York | | Media Releases Americas

The UBS Global Life Sciences Conference opens today at the Grand Hyatt in New York City and runs through Thursday, September 29. The Conference will feature presentations by more than 360 public and private companies representing biotechnology, medical device manufacturers, pharmaceuticals and specialty pharmaceutical.

The seventh annual UBS Global Life Sciences Conference is among the largest health care investor conferences in the world. Senior executives from the leading pharmaceutical, biotechnology and medical technology companies will provide their insight and outlook on the global life sciences industry. More than 3,400 people are expected to attend. Presenting companies include:


Actelion Ltd
Advanced Medical Optics, Inc.
Affymetrix, Inc.
Altana AG
Amgen Inc.
Amylin Pharmaceuticals Inc.
Applied Biosystems Group
Beckman Coulter, Inc.
Biogen IDEC Inc.
Biovail Corporation
Bristol-Myers Squibb Company
Caremark Rx. Inc.
Charles River Laboratories International Inc.
Chiron Corporation
Coloplast AS
Covance Inc.
DENTSPLY International Inc.
Edwards Lifesciences Corp.
Fisher Scientific International, Inc.
Forest Laboratories, Inc.
Fresenius AG
Genentech, Inc.
Gen-Probe Inc.
Genzyme Corporation
Gilead Sciences, Inc.
GN Store Nord A/S
ImClone Systems Incorporated
Intuitive Surgical, Inc.
Invitrogen Corporation
Kinetic Concepts, Inc.
Kos Pharmaceuticals
Laboratory Corporation of America Holdings
Lonza Group AG
MedImmune, Inc.
Mentor Corporation
Mettler-Toledo International Inc.
MGI Pharma, Inc.
Millipore Corporation
Novartis AG
Novo Nordisk AS
Pall Corporation
PerkinElmer, Inc.
Pharmaceutical Product Development, Inc.
Protein Design Labs, Inc.
QIAGEN NV
Quest Diagnostics Incorporated
Respironics
Roche Holdings AG
Schwarz Pharma AG
Serono S.A.
Siemens AG
Stericycle Inc.
Thermo Electron Corporation
UCB SA
Waters Corporation
Wyeth


Online conference information To access audio transmissions and the conference agenda please go to the UBS Investment Bank website at www.ibb.ubs.com. Audio transmissions of company presentations will be available live and by replay. Replays will begin three hours after the actual presentation time and will be available on the site for a period of four weeks.

UBS Investment Bank is a business group of UBS AG (NYSE: UBS), one of the world's leading financial firms. The investment banking and securities business is among the select bracket of major global houses, providing a full range of products to institutional and corporate clients, intermediaries, governments and hedge funds. UBS employs around 69,000 people in 50 countries and is listed on the New York, Tokyo and Zurich stock exchanges.



Inquiries:

Allison Chin-Leong 212-882-5693

New York, September 26, 2005
UBS